Möchten Sie immer auf dem neuesten Stand bleiben?

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with...

DOVER, USA, March 27, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced...

A federal court granted class and collective certification to thousands of participants in Salvation Army Adult Rehabilitation Centers.

Internet pioneer Michael Weiss joins Media.com board to advance its digital trust infrastructure, bringing top expertise as the firm preps for Series A.

Landmark decision by CHMP grants approval for self or caregiver administration for patients living with multiple myeloma1 Milestone is a testament to ten years of daratumumab experience and...

BEIJING, March 27, 2026 (GLOBE NEWSWIRE) -- Against the backdrop of deepening financial cooperation in the Global South, and global push for renewable energy, a 950MW Concentrated Solar Power and...

NEW HAVEN, Conn., March 26, 2026 (GLOBE NEWSWIRE) -- CT United FC, a new professional men’s soccer club set to compete in MLS NEXT Pro, proudly celebrates its Academy U15 boys, who have made history...

Advancing first-to-market autoimmune CAR T opportunity in stiff person syndrome (SPS) with key launch preparation activities underway; BLA submission anticipated in 1H 2026 Progressing enrollment...

Ghent, Belgium, March 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE REGULATED INFORMATION - INSIDE INFORMATION26 March 2026, 8:00 pm CET Ghent, Belgium, 26 March 2026 – Sequana Medical NV (Euronext...